Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Hepatitis C

Free Subscription Articles published in J Virol Retrieve available abstracts of 16 articles: HTML format

Single Articles

January 2025
1. FEDORCHENKO SV, Klimenko Z, Martynovich T, Solianyk I, et al
   Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.
   J Virol. 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
   PubMed     Abstract available
   
   
   June 2024
2. LIU J, Ito M, Liu L, Nakashima K, et al
   Involvement of ribosomal protein L17 and Y-box binding protein 1 in the assembly of hepatitis C virus potentially via their interaction with the 3' untranslated region of the viral genome.
   J Virol. 2024 Jun 20:e0052224. doi: 10.1128/jvi.00522.
   PubMed     Abstract available
   
   
   March 2024
3. TAMURA T, Yamamoto H, Ogino S, Morioka Y, et al
   A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation.
   J Virol. 2024;98:e0163823.
   PubMed     Abstract available
   
   
   February 2024
4. FRERICKS N, Brown RJP, Reinecke BM, Herrmann M, et al
   Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
   J Virol. 2024 Feb 6:e0192123. doi: 10.1128/jvi.01921.
   PubMed     Abstract available
   
   
   January 2024
5. CASIANO MATOS J, Harichandran K, Tang J, Sviridov DO, et al
   Hepatitis C virus E1 recruits high-density lipoprotein to support infectivity and evade antibody recognition.
   J Virol. 2024 Jan 4:e0084923. doi: 10.1128/jvi.00849.
   PubMed     Abstract available
   
   
   December 2023
6. HAGA Y, Meyer K, Sung MMH, Reagan EK, et al
   Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine facilitates human immune cell activation.
   J Virol. 2023 Dec 12:e0180923. doi: 10.1128/jvi.01809.
   PubMed     Abstract available
   
   
   
7. GOBRAN ST, Pagliuzza A, Khedr O, Fert A, et al
   DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people.
   J Virol. 2023 Dec 5:e0110523. doi: 10.1128/jvi.01105.
   PubMed     Abstract available
   
   
   November 2023
8. BAJPAI PS, Collignon L, Solund C, Madsen LW, et al
   Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone.
   J Virol. 2023 Nov 21:e0092523. doi: 10.1128/jvi.00925.
   PubMed     Abstract available
   
   
   October 2023
9. LI Y, Yang Y, Li T, Wang Z, et al
   Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
   J Virol. 2023 Oct 3:e0109023. doi: 10.1128/jvi.01090.
   PubMed     Abstract available
   
   
   September 2023
10. NEPAL S, Holmstrom ED
    Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein.
    J Virol. 2023 Sep 29:e0089223. doi: 10.1128/jvi.00892.
    PubMed     Abstract available
    
    
    
11. FELLENBERG J, Dubrau D, Isken O, Tautz N, et al
    Packaging defects in pestiviral NS4A can be compensated by mutations in NS2 and NS3.
    J Virol. 2023;97:e0057223.
    PubMed     Abstract available
    
    
    June 2023
12. PANIGRAHI M, Palmer MA, Wilson JA
    Enhanced Virus Translation Enables miR-122-Independent Hepatitis C Virus Propagation.
    J Virol. 2023 Jun 20:e0085821. doi: 10.1128/jvi.00858.
    PubMed     Abstract available
    
    
    
13. AVULA K, Singh B, Samantaray S, Syed GH, et al
    The Early Secretory Pathway Is Crucial for Multiple Aspects of the Hepatitis C Virus Life Cycle.
    J Virol. 2023 Jun 20:e0018023. doi: 10.1128/jvi.00180.
    PubMed     Abstract available
    
    
    
14. TOON K, Kalemera MD, Palor M, Rose NJ, et al
    GB Virus B and Hepatitis C Virus, Distantly Related Hepaciviruses, Share an Entry Factor, Claudin-1.
    J Virol. 2023 Jun 13:e0046923. doi: 10.1128/jvi.00469.
    PubMed     Abstract available
    
    
    
15. ABE T, Marutani Y, Deng L, Matsui C, et al
    Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Calpha (PKCalpha) and PKCeta Expression, Thereby Promoting Viral Propagation.
    J Virol. 2023 Jun 5:e0065523. doi: 10.1128/jvi.00655.
    PubMed     Abstract available
    
    
    April 2023
16. WOLFISBERG R, Holmbeck K, Billerbeck E, Thorselius CE, et al
    Molecular Determinants of Mouse Adaptation of Rat Hepacivirus.
    J Virol. 2023;97:e0181222.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.